Customer valuation is crucial to success and survival. What approaches should pharma be taking to ensure that it achieves customer valuation from discovery through to development and commercialisation? CLick here to download this article:
Counting the cost of carbon to shareholders: Taking first steps
Companies are facing the prospect of being taxed on greenhouse gas (GHG) emissions, which could reduce profitability and, ultimately, shareholder value. Our...